Barclays PLC increased its stake in elf Beauty, Inc. (NYSE: ELF – Get Rating) by 140.8% in the third quarter, according to the latest disclosure to the SEC. Institutional investors owned 114,546 shares in the company after acquiring an additional 66,976 shares during this period. Barclays PLC owned approximately 0.22% of elf Beauty, valued at $4,309,000, as of its latest filing with the SEC.
→ Is this the end of capitalism? (From Porter & Co.)
Other institutional investors and hedge funds have also bought and sold shares of the company. Covestor Ltd increased its stake in elf Beauty by 8,340.0% in the first quarter. Covestor Ltd now owns 1,266 shares of the company, valued at $33,000, after acquiring an additional 1,251 shares in the previous quarter. Counterpoint Mutual Funds LLC purchased new shares of elf Beauty worth approximately $110,000 in the third quarter. KBC Group NV purchased new shares in elf Beauty worth approximately $120,000 in the second quarter. Advisor Group Holdings Inc. upped his stake in elf Beauty by 7.6% in the first quarter. Advisor Group Holdings Inc. now owns 6,765 of his shares worth $174,000 after purchasing an additional 476 shares during this period. Finally, Penserra Capital Management LLC increased its stake in elf Beauty by 67.7% in the first quarter. Penserra Capital Management LLC now owns 7,826 shares of the company stock valued at $202,000 after purchasing an additional 3,158 shares during this period. Institutional investors own 95.14% of the company’s shares.
Elf Beauty Trading Down 2.2%
ELF shares opened at $56.66 on Monday. The stock has a 50-day moving average price of $54.63 and a 200-day moving average price of $44.91. The company has a market cap of $3 billion, a PE ratio of 89.94, a P/E/G ratio of 2.72, and a beta of 1.54. For elf Beauty, Inc., his 52-week low is $20.49 and his 52-week high is $58.76. The company has an equity ratio of 0.25, a quick ratio of 2.31 and a current ratio of 3.44.
elf Beauty (NYSE:ELF – Get Rating) announced final results on Wednesday, November 2nd. The company reported that he earned $0.22 per share for the quarter, beating analyst consensus expectations of $0.10 for him by $0.12. The company’s revenue for the quarter was $122.35 million, compared to consensus expectations of $106.29 million. elf Beauty had a return on equity of 11.83% and a net profit margin of 7.57%. Equity analysts expect elf Beauty, Inc. to have EPS of 0.78 for the current fiscal year.
Insider trading at elf Beauty
In other elf Beauty news, CEO Tarang Amin sold 100,000 shares in the company in a transaction on Thursday, November 3rd. The shares sold at an average price of $46.01 for a total of $4,601,000.00. After the sale, the CEO now owns 347,496 shares of the company stock valued at approximately $15,988,290.96. The sale is disclosed in documents filed with the SEC and available on his website. In related news, insider Scott Milsten sold 55,000 shares of the company’s stock in a transaction on Monday, January 9th. The shares were sold at an average price of $56.98, and the transaction totaled him $3,133,900.00. After the sale, insiders now own 127,560 shares of the company stock valued at approximately $7,268,368.80. The transaction is disclosed in documents filed with the SEC and available at this hyperlink. CEO Tarang Amin also sold 100,000 shares of the company in a transaction on Thursday, November 3rd. The shares sold at an average price of $46.01 for a total of $4,601,000.00. After the sale, the CEO now owns directly his 347,496 shares in the company, valued at approximately $15,988,290.96. Please see here for the disclosure of this sale. Last quarter, the insider sold 194,740 shares of his company stock worth $9,942,854. His 8.20% of the shares are now owned by corporate insiders.
Analyst sets new price target
Several analysts have published reports on the company. Piper Sandler raised her target price for elf Beauty from her $55.00 to her $64.00 in her research notes on Tuesday, January 3rd. Stifel Nicolaus raised elf Beauty’s price target from her $43.00 to her $50.00, giving the company a “Hold” rating in a research note on Tuesday, Jan. 24. DA Davidson raised elf Beauty’s price target from her $44.00 to $54.00, giving the company a “buy” rating in a research note on Thursday, Nov. 3. Raymond James has raised his price target for elf Beauty to $63.00 from his $50.00, giving the company an “excellent” rating in Thursday’s research notes. Finally, StockNews.com began coverage of elf Beauty in his Wednesday Oct. 12 investigative note. They issued a “Hold” rating on the stock. Equity Research 5 of his analysts gave the stock a hold rating and 10 gave the stock a buy rating. According to MarketBeat, the company’s current consensus rating is “moderate buy” with a consensus target price of $55.36.
Elf Beauty Company Profile
(get rating)
elf Beauty, Inc, along with its subsidiaries, offers cosmetic and skin care products worldwide under the brand names elf Cosmetics, elf Skin, Well People, and Keys Soulcare. The company offers eye, lip, facial, face, foot, and skin care products. The Company sells its products through domestic and international retailers and direct-to-consumer channels, including e-commerce platforms in the United States, and primarily through distributors internationally.
Featured article
This instant news alert was generated by Narrative Science Technology and MarketBeat financial data to provide our readers with the fastest and most accurate reporting. This article was reviewed by MarketBeat’s editorial team prior to publication. Send any questions or comments about this story to contact@marketbeat.com.
Before you think about the beauty of elves, you’ll want to hear this.
MarketBeat tracks Wall Street’s most acclaimed and top performing research analysts and the stocks they recommend to clients every day. MarketBeat has identified five stocks top analysts are quietly whispering to clients to buy now before the broader market catches on…and Elf Beauty wasn’t on the list. .
While elf Beauty is currently rated as a ‘moderate buy’ among analysts, the top rated analysts believe these five stocks are better buys.
See 5 stocks here
